Category | 1994–1999 | 2000–2009 | 2010–2016 | Total | ||||
---|---|---|---|---|---|---|---|---|
N | % | N | % | N | % | N | % | |
Aggressive B-cell lymphoma | 10 | 23.8 | 46 | 28.6 | 49 | 21.3 | 105 | 24.3 |
Indolent lymphoma | 14 | 33.3 | 47 | 29.2 | 46 | 20.0 | 107 | 24.7 |
Of which transformed | 4 | 28.6 | 31 | 66.0 | 35 | 76.1 | 70 | 65.4 |
Mantle cell lymphoma | 2 | 4.8 | 27 | 16.8 | 55 | 23.9 | 84 | 19.4 |
T-cell lymphoma | 6 | 14.3 | 23 | 14.3 | 37 | 16.1 | 66 | 15.2 |
Hodgkin lymphoma | 10 | 23.8 | 18 | 11.2 | 23 | 10.0 | 51 | 11.8 |
Primary CNS lymphoma | 0 | 0 | 0 | 0 | 20 | 8.7 | 20 | 4.6 |
Harvest < 5 million CD34 +/kg | 22 | 64.7 | 36 | 23.2 | 51 | 22.2 | 109 | 26.0 |
Upfront transplantation | 3 | 7.1 | 46 | 28.6 | 106 | 46.1 | 155 | 35.8 |
Age > 65 years | 0 | 0 | 19 | 11.8 | 66 | 28.7 | 85 | 19.6 |
100-day overall mortality | 4 | 9.5 | 14 | 8.7 | 13 | 5.7 | 31 | 7.2 |
100-day non-relapse mortality | 4 | 9.5 | 11 | 7.0 | 9 | 4.0 | 24 | 5.6 |
100-day lymphoma mortality | 0 | 0 | 3 | 2.0 | 4 | 1.8 | 7 | 1.7 |
6-month overall mortalitya | 14.3 | 13.1 | 7.4 | 10.2 | ||||
6-month non-relapse mortalitya | 11.9 | 6.0 | 3.9 | 6.3 | ||||
6-month lymphoma mortalitya | 2.7 | 5.3 | 3.6 | 4.2 | ||||
1-year overall mortalitya | 28.6 | 19.9 | 16.6 | 19.0 | ||||
1-year non-relapse mortalitya | 17.1 | 6.8 | 4.4 | 7.6 | ||||
1-year lymphoma mortalitya | 13.8 | 11.5 | 12.8 | 12.4 |